Fast-Acting depression relief tested for patients in palliative care
NCT ID NCT02783430
Summary
This study tested whether adding the drug ketamine to a standard antidepressant could help control depression symptoms faster in patients with serious, progressive illnesses who are receiving palliative care. It involved 42 hospitalized patients with moderate-to-severe depression. Half received ketamine plus the antidepressant milnacipran, while the other half received a placebo plus milnacipran, to see which combination worked better.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
C.H de Roubaix
Roubaix, France
-
Centre Hospitalier de Valenciennes
Valenciennes, France
-
Ch Calais
Calais, France
-
Ch Ghpso Senlis
Senlis, France
-
Ch Tourcoing
Tourcoing, France
-
Chu Amiens Picardie
Amiens, France
-
Groupt Hopitaux Instit Catho de Lille - Lomme
Lomme, France
-
Maison Medicale Jean Xxiii - Lille
Lille, 59037, France
-
University Hospital,
Lille, France
Conditions
Explore the condition pages connected to this study.